Related references
Note: Only part of the references are listed.Conjunctival Melanoma Outcomes Based on Tumor Origin in 382 Consecutive Cases
Carol L. Shields et al.
OPHTHALMOLOGY (2011)
Subconjunctival/Perilesional Recombinant Interferon α2b for Ocular Surface Squamous Neoplasia A 10-Year Review
Carol L. Karp et al.
OPHTHALMOLOGY (2010)
Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma?
Joshua C. Mandrell et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2009)
Keratin and filaggrin expression in keratoacanthoma
Yoshiyuki Ito et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Keratoacanthoma: a tumor in search of a classification
Amel Karaa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
Intralesional interferon alfa-2b treatment of keratoacanthomas
CK Oh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Tumors of the conjunctiva and cornea
CL Shields et al.
SURVEY OF OPHTHALMOLOGY (2004)
Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy
CL Shields et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
Share Paper
